IL96370A - חומצות אזאהטרוציקליות קרבוקסיליות n-מותמרות ואסטרים שלהן, הכנתם ותכשירי רוקחות המכילים אותם - Google Patents

חומצות אזאהטרוציקליות קרבוקסיליות n-מותמרות ואסטרים שלהן, הכנתם ותכשירי רוקחות המכילים אותם

Info

Publication number
IL96370A
IL96370A IL9637090A IL9637090A IL96370A IL 96370 A IL96370 A IL 96370A IL 9637090 A IL9637090 A IL 9637090A IL 9637090 A IL9637090 A IL 9637090A IL 96370 A IL96370 A IL 96370A
Authority
IL
Israel
Prior art keywords
added
mixture
ethyl
solution
stirred
Prior art date
Application number
IL9637090A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL96370A publication Critical patent/IL96370A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
IL9637090A 1989-11-22 1990-11-16 חומצות אזאהטרוציקליות קרבוקסיליות n-מותמרות ואסטרים שלהן, הכנתם ותכשירי רוקחות המכילים אותם IL96370A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer

Publications (1)

Publication Number Publication Date
IL96370A true IL96370A (he) 1995-01-24

Family

ID=8145900

Family Applications (2)

Application Number Title Priority Date Filing Date
IL69370A IL96370A0 (en) 1989-11-22 1990-11-16 N-substituted azaheterocyclic carboxylic acids and esters thereof,their preparation and pharmaceutical compositions containing them
IL9637090A IL96370A (he) 1989-11-22 1990-11-16 חומצות אזאהטרוציקליות קרבוקסיליות n-מותמרות ואסטרים שלהן, הכנתם ותכשירי רוקחות המכילים אותם

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL69370A IL96370A0 (en) 1989-11-22 1990-11-16 N-substituted azaheterocyclic carboxylic acids and esters thereof,their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5198451A (he)
EP (1) EP0502031B1 (he)
JP (1) JPH05503083A (he)
AT (1) ATE157086T1 (he)
AU (1) AU660919B2 (he)
CA (1) CA2073189C (he)
DE (1) DE69031312T2 (he)
DK (2) DK588189D0 (he)
FI (1) FI97541C (he)
IE (1) IE904155A1 (he)
IL (2) IL96370A0 (he)
NO (1) NO177853C (he)
NZ (1) NZ236155A (he)
PT (1) PT95970B (he)
WO (1) WO1991007389A1 (he)
ZA (1) ZA909305B (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
JP2000511538A (ja) * 1996-05-24 2000-09-05 スミスクライン・ビーチャム・コーポレイション 鎮咳剤としてのgaba取り込み阻害剤の使用
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
PT84064B (pt) * 1986-01-07 1989-07-31 Novo Industri As Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
NO177853C (no) 1995-12-06
NO921852L (no) 1992-05-11
CA2073189C (en) 1998-04-07
NO921852D0 (no) 1992-05-11
WO1991007389A1 (en) 1991-05-30
IE904155A1 (en) 1991-05-22
NO177853B (no) 1995-08-28
DK0502031T3 (da) 1998-03-30
US5198451A (en) 1993-03-30
JPH05503083A (ja) 1993-05-27
FI97541C (fi) 1997-01-10
DE69031312D1 (de) 1997-09-25
FI97541B (fi) 1996-09-30
FI922268A (fi) 1992-05-19
EP0502031A1 (en) 1992-09-09
AU6746490A (en) 1991-06-13
IL96370A0 (en) 1991-08-16
PT95970B (pt) 1998-01-30
ZA909305B (en) 1991-09-25
ATE157086T1 (de) 1997-09-15
DE69031312T2 (de) 1998-02-26
AU660919B2 (en) 1995-07-13
PT95970A (pt) 1991-09-13
CA2073189A1 (en) 1991-05-23
FI922268A0 (fi) 1992-05-19
DK588189D0 (da) 1989-11-22
EP0502031B1 (en) 1997-08-20
NZ236155A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
US5071859A (en) N-substituted azaheterocyclic carboxylic acids and pharmaceutical uses
US5874428A (en) N-substituted aza-heterocyclic carboxylic acids and esters thereof
EP0585314B1 (en) Novel heterocyclic carboxylic acids
US5604242A (en) Heterocyclic chemistry
HU187480B (en) Process for producing 1-bracket-4-quinolyl-bracket closed-2-bracket-4-piperidyl-bracket closed-ethanol and 1-bracket-4-quinolyl-bracket closed-3-bracket-4-piperidiyl-bracket closed-propanol and pharmaceutival compositions containing them as active agents
IL96370A (he) חומצות אזאהטרוציקליות קרבוקסיליות n-מותמרות ואסטרים שלהן, הכנתם ותכשירי רוקחות המכילים אותם
US5214057A (en) N-substituted azaheterocyclic carboxylic acids
US5635518A (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
US5639766A (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
US5608069A (en) 1-substituted, 3-carboxylic acid piperidine derivatives
CZ198396A3 (en) Pharmaceutical preparation for treating neurogenous inflammations

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees